NCT02588729

Brief Summary

In this study, the investigators will test a new way to communicate advice on diet and lifestyle to women with gestational diabetes mellitus by app downloaded on women's smartphone. The app wishes to motivate women to have a healthy diet, and be physically active. It allows automatic transfer of blood glucose measures from the glucose meter to the smartphone. The women will answer questionnaires during pregnancy and be followed up three months postpartum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
238

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 28, 2015

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

2.2 years

First QC Date

August 31, 2015

Last Update Submit

April 4, 2018

Conditions

Keywords

Gestational diabetesappRCTdietphysical activity

Outcome Measures

Primary Outcomes (1)

  • Oral glucose tolerance test (OGTT), fasting and 2 hours blood glucose level after intake up til 75gr glucose (1.75gr/kg body weight)

    Part of routine care for women who had GDM, is an OGTT about three months postpartum, taken at their laboratory and reported to the investigators.Number of participants with level below 7.5 mmol

    Approximately three months after delivery.

Secondary Outcomes (13)

  • complications of pregnancy

    Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum

  • Dietary intake measured by "Fit for fødsel Food questionnaire"

    Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum

  • Knowledge of gestational diabetes

    Data will be collected prior to 33 weeks gestation, and at 36 weeks gestation

  • Physical activity

    Data wil be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum

  • Depression

    Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum

  • +8 more secondary outcomes

Study Arms (2)

Pregnant+ app for smartphone (Gravid+)

EXPERIMENTAL

The intervention consists of the Pregnant+app downloaded on women's smartphone. The app contains culturally adapted information about physical activity, diet and management of GDM. The Gravid+app will be available in Norwegain, Urdu and Somali. Women will have the opportunity to automatically transfer their blood glucose levels to their smartphones via Bluetooth.

Other: Pregnant+ app for smartphone

No admission to Pregnant+ app (Gravid+)

NO INTERVENTION

The control group will receive standard care at the outpatient departments. Participants to not receive the Pregnancy

Interventions

The Pregnant+app for smartphone with information about a healthy diet, physical activity and management of gestational diabetes mellitus.

Pregnant+ app for smartphone (Gravid+)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First visit with gestational diabetes in this pregnancy
  • Has her own smartphone
  • Pregnancy up to 32 weeks and 6 days of gestation
  • Fluent in Norwegian, Urdu or Somali
  • Aged 18 years old and older

You may not qualify if:

  • Pregnant with more than one fetus
  • Lactose or gluten intolerance
  • Known type 1 diabetes (insulin dependent)
  • Known type 2 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo university hospital

Oslo, 4950, Norway

Location

Related Publications (5)

  • Garnweidner-Holme LM, Borgen I, Garitano I, Noll J, Lukasse M. Designing and Developing a Mobile Smartphone Application for Women with Gestational Diabetes Mellitus Followed-Up at Diabetes Outpatient Clinics in Norway. Healthcare (Basel). 2015 May 21;3(2):310-23. doi: 10.3390/healthcare3020310.

    PMID: 27417764BACKGROUND
  • Garnweidner-Holme L, Henriksen L, Bjerkan K, Lium J, Lukasse M. Factors associated with the level of physical activity in a multi-ethnic pregnant population - a cross-sectional study at the time of diagnosis with gestational diabetes. BMC Pregnancy Childbirth. 2022 Jan 3;22(1):1. doi: 10.1186/s12884-021-04335-x.

  • Garnweidner-Holme L, Henriksen L, Torheim LE, Lukasse M. Effect of the Pregnant+ Smartphone App on the Dietary Behavior of Women With Gestational Diabetes Mellitus: Secondary Analysis of a Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Nov 4;8(11):e18614. doi: 10.2196/18614.

  • Borgen I, Smastuen MC, Jacobsen AF, Garnweidner-Holme LM, Fayyad S, Noll J, Lukasse M. Effect of the Pregnant+ smartphone application in women with gestational diabetes mellitus: a randomised controlled trial in Norway. BMJ Open. 2019 Nov 11;9(11):e030884. doi: 10.1136/bmjopen-2019-030884.

  • Borgen I, Garnweidner-Holme LM, Jacobsen AF, Bjerkan K, Fayyad S, Joranger P, Lilleengen AM, Mosdol A, Noll J, Smastuen MC, Terragni L, Torheim LE, Lukasse M. Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial. BMJ Open. 2017 Mar 27;7(3):e013117. doi: 10.1136/bmjopen-2016-013117.

MeSH Terms

Conditions

Diabetes, GestationalAlzheimer DiseaseMotor Activity

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersBehavior

Study Officials

  • Mirjam Lukasse, PhD

    Oslo Metropolitan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 31, 2015

First Posted

October 28, 2015

Study Start

October 1, 2015

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

April 5, 2018

Record last verified: 2018-04

Locations